Protocol Library

Each card lists peptide research notes — vial size, example research dose range, reconstitution example, frequency example, cycle length example, and risk level. All entries are educational. Not medical advice.

Research use only. Educational content. Not medical advice, diagnosis, treatment, or a personal recommendation. Not intended for human consumption. Always discuss with a qualified healthcare professional.

Adamax

moderate risk

Commonly researched for cognitive focus, attention research, neuroprotection research and BDNF-related signaling discussion.

Vial: 5 mg
Dose: Research literature commonly cites 200–600 mcg per research day intranasal-equivalent in published protocols.
Freq: Once or twice daily in research scheduling examples.
Cycle: 10–20 days per research cycle.

cognitivestress-mood

Cerebrolysin

moderate risk

Studied for its role in neurotrophic signaling, cognitive research and post-ischemic neurological research models.

Vial: 5 ml ampoule
Dose: Published clinical research commonly cites 5–30 ml per research day intravenous-equivalent ranges.
Freq: Daily research dosing across multi-week courses in published studies.
Cycle: Common research courses: 10–30 days.

cognitivelongevity

Cortagen

low risk

Commonly researched for cognitive, neuroprotection and nervous-system bioregulator contexts.

Vial: 20 mg
Dose: Research literature commonly references 100–200 mcg per research day.
Freq: Once daily in research scheduling examples.
Cycle: 10–20 days per research cycle.

cognitivebioregulators

Oxytocin

high risk

Studied for its role in neuropeptide signaling research, stress research, social behavior research and mood-related research.

Vial: 2 mg
Dose: Research literature references microgram intranasal-equivalent ranges (e.g. 20–40 IU per research session in intranasal protocols).
Freq: As-needed scheduling in many study models.
Cycle: Short research periods.

stress-moodcognitive

Pinealon

low risk

Investigated for neuroprotective signaling in preclinical research literature.

Vial: 20 mg lyophilized vial
Dose: Educational research dose example only.
Freq: Daily in short research cycles.
Cycle: 10–20 day educational example.

cognitivelongevitystress-mood

Selank

low risk

Researched in GABAergic and anxiolytic contexts.

Vial: 10 mg
Dose: 250–500 mcg daily (research literature, intranasal common)
Freq: 1–2x daily (research example)
Cycle: 2–4 weeks (research example)

stress-moodcognitive

Semax

low risk

Researched in BDNF and cognitive performance contexts.

Vial: 30 mg
Dose: 200–600 mcg daily (research literature, intranasal common)
Freq: 1–2x daily (research example)
Cycle: 2–4 weeks (research example)

cognitivestress-mood

Verified Research Supplier

Looking for a research supplier?

Enhanced Performance is a separate research supply platform. Visiting or purchasing is optional and not required to use PepToolbox.

Visit Enhanced Performance

Disclosure: Enhanced Performance is a separate platform connected to the owner of this website. Purchasing is optional and not required to use this tool.